Quick Summary
Most GLP-1 side effects are digestive, tend to show up early or after a dose increase, and often ease as your body adjusts. A smaller number of effects are rare but serious enough to know the warning signs. This isn't a reason to hesitate, it's context, so nothing catches you off guard.
If you've looked into GLP-1s at all, you've probably seen the side-effect lists: long, clinical, and a little alarming when they're presented without context.
So let's put them into context.
Most side effects reported with GLP-1 medications are digestive, tend to be more noticeable when starting treatment or increasing the dose, and often improve as your body adjusts. But "common" doesn't mean you have to suffer through it, and knowing the difference between an expected side effect and a reason to reach out to your provider matters.
Side effects can happen because GLP-1 medications affect the same systems that regulate appetite and digestion. Experiencing them doesn't necessarily mean something is wrong, but severity matters.
What tends to show up early (and usually settles down):
The first few weeks, and right after any dose increase, are when most people notice something. The most frequently reported effects are digestive: nausea tops the list, followed by changes in bowel habits, some fatigue, and occasional stomach discomfort. For most people, this eases within a matter of weeks as the body adjusts to the new dose.
What can actually help:
-Eat smaller meals.
-Eat slowly, and stop when you're comfortably full.
-Avoid very large or high-fat meals if they worsen nausea.
-Stay hydrated.
-Don't suddenly increase your food intake just because you have a "good" day.
-Try home remedies - ginger, for example, may be helpful for nausea.
-Keep track of when symptoms happen, particularly around dose increases.
-Tell your provider if symptoms are persistent, worsening, or interfering with eating or drinking.
What's less common, but worth actually knowing:
A smaller share of people notice things like injection-site irritation, headaches, or changes in resting heart rate. These are worth flagging to your provider, not necessarily worth panicking over.
What's rare, but where you should never wait to ask:
There's a short list of more serious risks associated with this medication class, gallbladder issues, pancreatitis, and a few others. Worth being aware of, even though they're uncommon.
Some symptoms warrant prompt medical attention: severe or persistent abdominal pain, especially if it radiates to the back; repeated vomiting or inability to keep fluids down; signs of dehydration; yellowing of the skin or eyes; or other severe or rapidly worsening symptoms. These aren't something to simply push through, contact your healthcare provider or seek urgent medical care depending on severity.
The part that doesn't get said enough:
The first few weeks can feel harder than expected. Knowing what may be normal, what can help, and when something deserves more attention can make the experience feel a lot less uncertain. That's where having the right information matters.
Worth reading next: what the research says about muscle loss on GLP-1s.
This article is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any health or wellness routine. This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before starting, stopping, or making changes to any medication or treatment plan. Compounded medications are not themselves FDA-approved products.
Sources & Further Reading
Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. "Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss." JAMA. 2023;330(18):1795–1797. — Examines gastrointestinal adverse events associated with semaglutide and liraglutide in a real-world population.
FDA Prescribing Information — Wegovy (semaglutide). — Provides clinical-trial data on common adverse reactions, including gastrointestinal effects and their occurrence during dose escalation.
FDA Prescribing Information — Zepbound (tirzepatide). — Provides clinical-trial data on common adverse reactions, including gastrointestinal effects and their occurrence during dose escalation.